TP53 and neoplasm: Interestingly, although the tumor specificity of DNA analysis is usually higher than that of RNA or proteins, white blood cells (and probably also other cell types) can harbor tumor‐specific mutations of the KRAS or TP53 genes (and others) in particular in aging individuals (Lo et al, 2021).